39.09
price down icon9.24%   -3.98
after-market Handel nachbörslich: 39.10 0.010 +0.03%
loading

Springworks Therapeutics Inc Aktie (SWTX) Neueste Nachrichten

pulisher
01:01 AM

SpringWorks Therapeutics (NASDAQ:SWTX) Shares Up 5.5%Time to Buy? - MarketBeat

01:01 AM
pulisher
Apr 03, 2025

NEOS Investment Management LLC Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Apr 03, 2025
pulisher
Apr 03, 2025

Pictet Asset Management Holding SA Has $86.40 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Apr 03, 2025
pulisher
Apr 01, 2025

SpringWorks Therapeutics Enters Oversold Territory (SWTX) - Nasdaq

Apr 01, 2025
pulisher
Mar 31, 2025

BIT Capital GmbH Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Segall Bryant & Hamill LLC Has $6.99 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 31, 2025
pulisher
Mar 30, 2025

Cibc World Markets Corp Acquires New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 30, 2025
pulisher
Mar 29, 2025

Swiss National Bank Has $4.22 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 2.5%Time to Sell? - MarketBeat

Mar 28, 2025
pulisher
Mar 25, 2025

SpringWorks Therapeutics Target of Unusually Large Options Trading (NASDAQ:SWTX) - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Recursion Pharma, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics - Barchart

Mar 24, 2025
pulisher
Mar 24, 2025

Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, - openPR

Mar 24, 2025
pulisher
Mar 24, 2025

Raymond James Financial Inc. Invests $10.53 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

46,895 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Platinum Investment Management Ltd. - MarketBeat

Mar 23, 2025
pulisher
Mar 21, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.8%Should You Sell? - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Short Interest Update - MarketBeat

Mar 21, 2025
pulisher
Mar 20, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

FDA’s new and supplemental approvals in February - BioCentury

Mar 19, 2025
pulisher
Mar 19, 2025

Bank of New York Mellon Corp Sells 30,986 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 19, 2025
pulisher
Mar 18, 2025

This Is What Whales Are Betting On SpringWorks Therapeutics - Benzinga

Mar 18, 2025
pulisher
Mar 17, 2025

SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Te - GuruFocus.com

Mar 17, 2025
pulisher
Mar 15, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Victory Capital Management Inc. - MarketBeat

Mar 15, 2025
pulisher
Mar 13, 2025

High Growth Tech Stocks In The US Market March 2025 - Simply Wall St

Mar 13, 2025
pulisher
Mar 13, 2025

How To Trade (SWTX) - Stock Traders Daily

Mar 13, 2025
pulisher
Mar 12, 2025

SpringWorks Therapeutics Inc (SWTX) Q4 2024 Earnings Report Prev - GuruFocus.com

Mar 12, 2025
pulisher
Mar 12, 2025

SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

SpringWorks Therapeutics, Inc.'s (NASDAQ:SWTX) Shares Climb 26% But Its Business Is Yet to Catch Up - Simply Wall St

Mar 12, 2025
pulisher
Mar 12, 2025

Victory Capital Management Inc. Reduces Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz - Seeking Alpha

Mar 11, 2025
pulisher
Mar 11, 2025

Traders Buy Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat

Mar 11, 2025
pulisher
Mar 10, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) CEO Saqib Islam Sells 49,000 Shares - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest? - MSN

Mar 10, 2025
pulisher
Mar 10, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) COO Badreddin Edris Sells 20,000 Shares - MarketBeat

Mar 10, 2025
pulisher
Mar 09, 2025

Candriam S.C.A. Reduces Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 09, 2025
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):